Hologic, Inc. unveils new research in artificial intelligence (AI) and offering innovative educational opportunities at the annual European Congress of Radiology (ECR) in Vienna, Austria.
Ordering preoperative breast MRI exams of diagnosed breast cancer patients used to be controversial: Did they aid surgical planning better than the combination of mammography and breast ultrasound? Or did their findings cause overtreatment, specifically mastectomy, when breast-conservation surgery would have sufficed? New research has now settled the issue.
Breast cancer has no “one size fits all” therapy approach: subtypes differ significantly in malignancy, progression, and treatment response. Therefore, the more is known about the type of carcinoma in a patient, the better the outcome. At the annual scientific EUSOBI meeting in Valencia, Dr Ramona Woitek pointed out the potential of novel imaging techniques and computational image analysis…
A new breast imaging technique provides high sensitivity for detecting cancer while significantly reducing the likelihood of false positive results, according to a new study.
Highlights The system is designed to drastically improve the screening and diagnostic throughput thanks to an high rotation speed and an improved vertical run speed. The gantry is ergonomically designed to give patients a natural and more relaxed positioning. The system is ppen to new AI application like the new algorithm for…
Highlights: Giotto Class is an advanced and innovative three dimensional breast imaging technology able to performDigital mammography and Breast TomosynthesisSynthesized 2D image generated from 3D datasetStereotactic biopsy in prone or upright positionIntegrated Real time biopsy tissue cores imagingContrast-Enhanced MammographyThe…
Highlights:New design for more comfort with improved readability and less eye fatigue, new battery management system and new casters Enriched user experience with a simpler workflow and better patient care Integrated with RIS and PACS (as an option) as well as with the scanner interface to reduce workload for the operator and improve patient turnaround times Limits patient risk by…
At the EUSOBI congress in Valencia, Hologic showcases its women's health portfolio, announces global partnerships for breast health - and even brings a sweet treat for the congressgoers.
A machine learning model found that background parenchymal enhancement (BPE) on breast MRI is an indicator of breast cancer risk in women with extremely dense breasts.
With the recent recommendation changes from the European Council in 2022, how radiologists screen for breast cancer is changing. Mammography has long been an essential technology in screening for breast cancer, and in the recommendations the Council formally recognized the advantages of digital breast tomosynthesis (DBT). This landmark acknowledges the research on and benefits of DBT, advocating…
The Accutron CT-D Vision is the next generation of the leading contrast agent injector for computed tomography from Medtron AG. Focusing on the needs of the user, the latest development stage of the Accutron CT-D improves the usability of the CT double-piston contrast agent injector and optimizes its integration into the radiological environment.
A new imaging approach using ultrafast MRI shows potential in predicting upgrade of ductal carcinoma in situ (DCIS) to invasive breast cancer at surgery.
The risk of developing breast cancer is higher in breasts with high density. But why is that? Researchers at Linköping University have shown major biological differences that promote cancer growth.
Multiparametric ultrasound (MPUS) has proven its value in the abdomen – now, the technique is increasingly moving towards peripheral areas such as breast and testis imaging, experts showed in a dedicated session at ECR 2022.
Contrast-enhanced mammography (CEM) has gone a long way since it was first approved by the Food and Drug Administration (FDA) in 2011. An Italian expert explained how useful the modality has become in breast imaging in a dedicated course at ECR 2022.
Contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with breast cancer who are unable to undergo MRI.
A software based on deep learning with convolutional neural networks can accurately and consistently classify breast density on mammograms according to BI-RADS criteria.
Digital breast tomosynthesis (DBT) increases detection of breast cancer in symptomatic women under the age of 60, especially in dense breasts. A large, multi-institutional study conducted in the United Kingdom comparing the sensitivity of full-field digital mammography (FFDM), DBT, and FFDM plus DBT supports findings of two similar published studies, both conducted in China in the same time frame.
MRI is the most sensitive method to detect breast cancer. However, the current breast cancer guidelines for Europe, Germany and Austria, still only recommend it for certain indications: For early detection in high risk patients, for differentiation between scarring and recurrences after breast-conserving treatment and to detect cancers of unknown primary site. This is the theory. However, in…
The field of AI-enhanced imaging provides radiologists with an unprecedented opportunity to shape patient care, leading Austrian radiologist Katja Pinker-Domenig explained at ECR 2020.
Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy, according to the results of a study presented by Mayo Clinic researchers at the 2017 San Antonio Breast Cancer Symposium. “Our study aimed to compare contrast-enhanced mammography with breast MRI in evaluating residual breast cancer in…
The ability to demonstrate blood perfusion as well as organ function using contrast agentenhanced ultrasound is quickly finding innovative uses in clinical practice. Contrast-enhanced ultrasound (CEUS) has advanced rapidly since its first introduction. Today it is widely used as a primary imaging technique for a number of indications and pathologies. At a symposium organised by Bracco Imaging…
Breast diagnostics are undergoing considerable change, with new technology facilitating alternative procedures. Genetics and nuclear medicine also enhance diagnostic possibilities. During our EH interview, Professor Rüdiger Schulz-Wendtland described current changes in breast diagnostics. ‘To date, complementary breast diagnostics has comprised clinical, sonographic and mammographic…
Installing a complete diagnostic radiology solution to network six sites of a hospital group, to process, manage and archive image data acquired across all modalities, is a ‘challenge’, acknowledged by Professor Dr Peter Landwehr, Medical Director of the Clinic for Diagnostic and Interventional Radiology of Diakovere Henriettenstift, Hanover, Germany. In 2010, he and his team overcame that…
A magnetic resonance (MR) breast imaging technique that uses no ionizing radiation or contrast agent could reduce unnecessary biopsies by providing additional information about suspicious findings on X-ray screening mammography, according to a new study published online in the journal Radiology.
A magnetic resonance spectroscopy (MRS) technique that monitors biochemical changes in tissue could improve the management of women at risk of breast cancer.
Why is early detection of breast cancer so important? Professor Dr Walter Heindel, Director of the Institute of Clinical Radiology at University Hospital Münster, Germany, offers an unequivocal answer.
Magnetic resonance imaging is a long-established, highquality and safe examination tool. Why, therefore, do German gynaecologists and radiologists question its value in breast cancer diagnoses? Indeed the question ‘Breast MRI - yes or no?’ has split the medical community. One ardent champion of breast MRI is Professor Christiane Kuhl MD, director of the diagnostic and interventional radiology…
The benfit of breast cancer screening for women over aged 50 is beyond doubt. However, what does a systematic search yield for breast cancer in women aged between 40 and 49? This question, which remains controversial, was raised again at ECR 2012.
No imaging modality is infallible -- not even mammography, the golden standard for early detection of breast cancer. Particularly in women with dense breast tissue, the diagnostic quality of conventional mammography frequently suffers in terms of sensitivity and specificity. However, the evolution of digital systems has produced technologies that optimise sensitivity as well as specificity and…
Standard mammography is the most relevant diagnostic tool to address breast cancer: It shows excellent image quality, a smooth workflow, high connectivity and a very good clinical outcome in terms of sensitivity and specificity. However, there are certain shortcomings to it, especially in dense breast tissue.
Standard mammography is the most relevant diagnostic tool to address breast cancer: It shows excellent image quality, a smooth workflow, high connectivity and a very good clinical outcome in terms of sensitivity and specificity. However, there are certain shortcomings to it, especially in dense breast tissue. Over the last 12 years, technical and clinical research is done with contrast-enhanced…
The limitations of mammography are well documented, yet it is still the gold standard in breast cancer detection - particularly due to the positive cost-benefit ratio. Due to prohibitive costs, MRI exams are performed only in well-defined cases. The HIGHREX project (www.highrex.eu) aims to evaluate Single Shot Spectral Imaging (SSSI) technology for use in mamma diagnostics.
Digital mammography, which is considered the gold standard of breast imaging, has rendered image management and consequently the entire – purely on-screen – diagnostic process more reliable and more efficient.
In a symposium organised by Bayer Schering Pharma at the 2009 European Congress of Radiology (ECR), the audience heard a series of four presentations on the potential advantages of high-signal-intensity contrast agents for MRI, focusing on gadobutrol (Gadovist). During the discussion, several claims made by the speakers were challenged and debated by ECR delegates.
A promising mammography screening technology By Andrew Smith PhD, principal scientist at Hologic, Inc. in Bedford, Mass, is involved in research and development of digital imaging systems.
Combining a scientific research laboratory with specialised clinic, the Netherlands Cancer Institute, in the Antoni van Leeuwenhoek Hospital (NKI-AVL), in Amsterdam, aims for a unique interaction of scientific research and clinical application.